C12N 2795/00034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2795/00034 (Use of virus or viral component as vaccine) appears on 33 US grants and 44 published applications in this corpus.
Search patents in C12N- Granted patents
- 33
- Published applications
- 44
- Assignees
- 17
- Inventors
- 57
- Latest grant
- 23 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 2 | 0 |
| 2012 | 0 | 3 |
| 2013 | 3 | 2 |
| 2014 | 2 | 2 |
| 2015 | 1 | 3 |
| 2016 | 3 | 3 |
| 2017 | 1 | 1 |
| 2018 | 4 | 5 |
| 2019 | 1 | 2 |
| 2020 | 3 | 4 |
| 2021 | 1 | 3 |
| 2022 | 2 | 1 |
| 2023 | 2 | 1 |
| 2024 | 3 | 3 |
| 2025 | 2 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Campylobacter bacteriophages and uses thereof23 Sep 2025US 12,419,313 B2Intralytix, Inc.
- Methods for treating and preventing diseases15 Apr 2025US 12,274,720 B2
- Melt processed viral nanoparticle constructs3 Dec 2024US 12,156,947 B2Case Western Reserve University
- Immunogenic composition3 Sep 2024US 12,076,352 B2Glaxosmithkline Biologicals SA
- Immunogenic composition4 Jun 2024US 11,998,579 B2Glaxosmithkline Biologicals SA
- Methods for treating and preventing diseases2 Apr 2026US 2026/0091068 A1
- Novel plant virus and bacteriophage vaccines26 Jun 2025US 2025/0205331 A1The Regents of the University of California
- Melt processed viral nanoparticle constructs19 Jun 2025US 2025/0195449 A1Case Western Reserve University
- Probiotic vaccines and related methods of use8 May 2025US 2025/0144193 A1Salvitus, Inc.
- Sars-cov-2 immunizing compositions and methods14 Nov 2024US 2024/0374713 A1
Most cited
By later US patents
- Compositions and methods for treatment of microbial infections20US 6,929,798 B2Immunology Laboratories, Inc. · 2005
- Compositions and methods for treatment of microbial infections16US 7,329,409 B2Immunology Laboratories, Inc. · 2008
- Compositions and methods for treatment of microbial infections12US 7,648,707 B2Immunology Laboratories, Inc. · 2010
- Compositions and methods for treatment of microbial infections10US 8,518,416 B2Immunology Laboratories, Inc. · 2013
- Compositions and methods for treatment of microbial infections8US 8,043,624 B2Immunology Laboratories, Inc. · 2011